Hypopharyngeal Carcinoma — Trials

Hypopharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

146 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 46
Recruiting: 28
Ph III recruiting: 4
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: 45.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (33)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04156698	Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma	unknown	Phase 2	51	Eye & ENT Hospital of Fudan UniversityOTHER	1	Aug 9, 2023	clinicaltrials
NCT04296747	Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer	unknown	Phase 2	100	Peking Union Medical College HospitalOTHER	0	Mar 5, 2020	clinicaltrials